Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic | Morningstar

[GlobeNewswire](/news/globe-newswire) Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic Genespire raises €46.6 million (~$52 million) in a Series B round to
Read more...